A natural broad-spectrum inhibitor of enveloped virus entry, effective against SARS-CoV-2 and Influenza A Virus in preclinical animal models.
R. Narayan, M. Sharma, R. T. Yadav, A. Biji, O. Khatun, R. S. Rajmani, P. R. Sharma, S. Jeyashankar, P. Rani, C. D. Rao, V. Satchidanandam, S. Das, R. Agarwal, S. Tripathi
This paper identifies picolinic acid as a broad-spectrum antiviral that inhibits enveloped virus entry, showing efficacy against SARS-CoV-2 and Influenza A Virus in animal models.
bioRxiv · Feb 16, 2022 · PreprintMicrobiology